---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-032567"
form_type: "8-K"
ticker: "RCEL"
cik: "0001762303"
company_name: "AVITA Medical, Inc."
filed_at: "2023-02-10T23:59:59+00:00"
generated_at: "2026-06-19T18:10:28.030828+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# AVITA Medical to report Q4/FY2022 results on Feb 23, 2023, provide 2023 guidance

## Summary
- Results due after market close on Thursday, Feb 23, 2023.
- Conference call at 1:30 p.m. PT (Feb 23) / 8:30 a.m. AEDT (Feb 24).
- Webcast available on ir.avitamedical.com; replay afterward.
- 2023 revenue guidance will be discussed on the call.

## SEC filing metadata
- accession: 0001193125-23-032567
- form_type: 8-K
- ticker: RCEL
- cik: 0001762303
- company_name: AVITA Medical, Inc.
- filed_at: 2023-02-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1762303/000119312523032567/0001193125-23-032567-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1762303/000119312523032567/d410703d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-032567
- JSON: https://secwatch.observer/filing/0001193125-23-032567.json
- Plain text: https://secwatch.observer/filing/0001193125-23-032567.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.